Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Leaps by Bayer

Profile, fund size and portfolio

Parent BayerHQ Berlin, GermanyFounded 2015

Leaps by Bayer is the corporate venture arm of Bayer, a pharmaceutical and biotech company. It was founded in 2015 and is based in Berlin, Germany. It invests from seed to Series B. Sectors it names: biotech and life sciences.

Cumulative investedS1
USD 2.1bn+
Companies backedS1
65+

Every figure links to its source

Snapshot

Investment stage: Seed to Series B
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series B
SectorsBiotech and life sciences
GeographyNorth America, Europe, Asia
OfficesBerlin, Germany, Boston, United States, Basel, Switzerland, Bay Area, United States, St. Louis, United States

Sources: S1 Leaps by Bayer approach (archived copy 2026; live site blocks bots); S7 Leaps by Bayer Annual Review 2025 (PDF).

Graphic 1 of 3

Investment stage: Seed to Series B

Sources: S1 Leaps by Bayer approach (archived copy 2026; live site blocks bots); S7 Leaps by Bayer Annual Review 2025 (PDF).

Download:Report a correction
Investments closed by company type
Data behind this graphic
Data behind this graphic
ItemCompaniesShare
Health4265.6%
Agriculture2234.4%

A company can carry more than one tag

Sources: S5 Leaps portfolio, health (archived copy 2025-08-03; page data feed has status, first investment date, website).

Graphic 2 of 3

Investments closed by company type

Sources: S5 Leaps portfolio, health (archived copy 2025-08-03; page data feed has status, first investment date, website).

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeUSD 2.1bn+Cumulative investedStated by the firm or its parentS1
Companies backed65+companiesStated by the firmS1
Companies on the firm's portfolio page64companiesCounted from the firm's own listS5

Sources: S1 Leaps by Bayer approach (archived copy 2026; live site blocks bots); S5 Leaps portfolio, health (archived copy 2025-08-03; page data feed has status, first investment date, website).

Graphic 3 of 3

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S1 Leaps by Bayer approach (archived copy 2026; live site blocks bots); S5 Leaps portfolio, health (archived copy 2025-08-03; page data feed has status, first investment date, website).

Download:Report a correction

Where it invests and who leads it

LeadersS4S2S3

Leaps by Bayer on LinkedIn

Key facts

FactValueStatusSource
Parent companyBayer (XETRA: BAYN)Single sourceS9
Parent industryPharmaceuticals and biotechSingle sourceS9
Founded2015Single sourceS7
HeadquartersBerlin, GermanySingle sourceS2
StatusActiveSingle sourceS9
Capital sourceParent company onlySingle sourceS1
Headline sizeUSD 2.1bn+ (Cumulative invested)Single sourceS1
Companies backed65+Single sourceS1
People on the team page18Single sourceS2
StagesSeed, Series A, Series BSingle sourceS1

Portfolio

The firm's portfolio page lists 64 companies: 48 active, 16 exited.S5

Companies by status on the firm's list. Status as the firm tags itS5
TagCompaniesShare
Active4875%
Exited1625%
Portfolio by the firm's own tags. A company can carry more than one tagS5
TagCompaniesShare
Health4265.6%
Agriculture2234.4%

Shared portfolio with other corporate VCs

18 companies on the Leaps by Bayer portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
Pfizer Ventures4Mozart Therapeutics, Capstan Therapeutics, ReCode Therapeutics, Pyxis Oncology
Sanofi Ventures4Nuvig Therapeutics, ReCode Therapeutics, Nextpoint Therapeutics, Sudo Biosciences
Bidra Innovation Ventures2EarthOptics, Apollo Agriculture
Cargill Ventures2Grão Direto, Andes
Ono Venture Investment2Mozart Therapeutics, Immunitas Therapeutics
CNH Ventures1EarthOptics
Cooperative Ventures1EarthOptics
Rabo Ventures1EarthOptics
BASF Venture Capital1Grão Direto
SLC Ventures1Grão Direto
Hitachi Ventures1Huma
Samsung Next1Huma

Companies backed by the most corporate VCs

Every company on the Leaps by Bayer list

64 companies, as listed on the firm's own website: 48 active, 16 exited.S5 Read the firm's list.

Active 48

  • 65Lab
  • Ada Health
  • Aferna Bio
  • Affini-T Therapeutics
  • AgBiome
  • Amfora
  • AMR Action Fund
  • Andes
  • Apollo Agriculture
  • Atomwise
  • Bloom Science
  • Capstan Therapeutics
  • Cellino
  • ChrysaLabs
  • CORXEL
  • Deka Biosciences
  • Dewpoint
  • EarthOptics
  • Edifice Health
  • eGenesis
  • Fork \u0026 Good
  • FutuRx
  • Gandeeva Therapeutics
  • Grão Direto
  • GRO Biosciences
  • Guardian Agriculture
  • Huma
  • Immunitas Therapeutics
  • Indapta Therapeutics
  • Khloris Biosciences
  • Kojin Therapeutics
  • Mozart Therapeutics
  • New Leaf Symbiotics
  • Nextpoint Therapeutics
  • NuCicer
  • Nuvig Therapeutics
  • Oerth Bio
  • One Drop
  • Pairwise
  • Paratus Sciences
  • Rantizo
  • Recode Therapeutics
  • Sound Agriculture
  • Sudo Biosciences
  • Triumvira Therapeutics
  • Ukko
  • Vesigen Therapeutics
  • Woebot Health

Exited 16

  • Arvinas
  • Azitra
  • BlueRock Therapeutics
  • Boundless Bio
  • Care/of
  • Casebia Therapeutics
  • Century Therapeutics
  • Combyne
  • CoverCress
  • CRISPR Therapeutics
  • Joyn Bio
  • Metagenomi
  • Pyxis Oncology
  • Recursion
  • Senti Bio
  • Unfold

For founders

ItemWhat the firm saysSource
StagesSeed, Series A, Series BS1
Leads roundsYesS10
Beyond capitalActive incubation: team members engage in company development, providing resources and helping steer the initial direction; Portfolio companies remain autonomous with respect to decision makingS1
Contact formleaps.bayer.com/contactS12

Notable outcomes

IPOs and acquisitions of portfolio companies. Price shown only where published.

CompanyTypeYearAcquirer or exchangePriceSource
Capstan TherapeuticsAcquisition2025AbbVieUSD 2.1bnS7
BlueRock TherapeuticsAcquisition2019BayerS7
Century TherapeuticsIPO2021NasdaqS7
RecursionIPO2021NasdaqS7

Recent rounds

DateCompanyRoundAmountSource
2026-07-14SabantoSeries BNot statedS10
2026-07-02Celea TherapeuticsNot statedUSD 180MS11
2026-06-01SonoThera TherapeuticsNot statedNot statedS9
2026-06-01Leaf, Inc.Not statedNot statedS9

Investments by year

YearTotalSource
202315S8
202520S7

History

  1. Leaps by Bayer founded; first investment in CRISPR Therapeutics and co-founded Casebia.S7
  2. Co-founded BlueRock Therapeutics.S7
  3. Invested in Century Therapeutics; BlueRock Therapeutics became part of Bayer.S7
  4. Century Therapeutics and Recursion listed on Nasdaq.S7
  5. Total invested passed USD 2 billion; first Chinese investment (CORXEL).S7
  6. Capstan Therapeutics acquired by AbbVie for USD 2.1 billion in cash.S7
  7. Led Sabanto Series B (14 Jul 2026); participated in Celea Therapeutics USD 180M financing (Reuters, 2 Jul 2026).S10

About Bayer

ItemDetailSource
Listed asXETRA: BAYNS9
HeadquartersGermanyS9

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Leaps by Bayer approach (archived copy 2026; live site blocks bots)Firm
  2. S2Leaps by Bayer teamFirm
  3. S3Leaps by Bayer team page (archived copy 2026-07-07, with LinkedIn links)Firm
  4. S4Juergen Eckhardt profile (leaps.bayer.com)Firm
  5. S5Leaps portfolio, health (archived copy 2025-08-03; page data feed has status, first investment date, website)Firm
  6. S6Leaps portfolio, agriculture (archived copy)Firm
  7. S7Leaps by Bayer Annual Review 2025 (PDF)Firm
  8. S8Leaps by Bayer Annual Review 2023 (PDF)Firm
  9. S9Bayer Half-Year Financial Report Q2 2026: Leaps by BayerParent company
  10. S10Sabanto and Leaps by Bayer announce Series B (PR Newswire)Portfolio company
  11. S11Reuters via 740 The FAN: PureTech entity Celea raises $180 millionPress
  12. S12Leaps by Bayer contact (archived copy)Firm
  13. S13Leaps by Bayer on LinkedInFirm
  14. S14Leaps by Bayer news page (archived copy)Firm

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Leaps by Bayer or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.